logo
Plus   Neg
Share
Email

JPMorgan To Remove Barriers To Employment For People With Criminal Backgrounds

JPMorgan Chase & Co. (JPM), a global financial services firm, said it will help people with criminal backgrounds build in-demand skills and gain access to employment through the company's new public policy agenda, investments in communities and own hiring strategy. The company plans to proactively remove all questions about criminal backgrounds from job applications.

As part of the efforts to create economic opportunity for more people, JPMorgan has launched the JPMorgan Chase PolicyCenter which will focus on issues such as job skills and education, small business capital and growth, community and economic development, infrastructure, affordable housing and financial health.

JPMorgan Chase & Co. has appointed Heather Higginbottom as President of the PolicyCenter. She previously served in senior policy roles in United States government, including Deputy Secretary of State, Deputy Director of the White House Office of Management and Budget, and Deputy Director of the White House Domestic Policy Council.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amity Packing Company Inc. is recalling around 2,020 pounds of raw ground beef products for possible plastic presence, the U.S. Department of Agriculture's Food Safety and Inspection Service stated. The agency said the products may be contaminated with extraneous materials, specifically clear, thin pliable plastic. The recall was initiated after Pre Brands LLC received two consumer complaints. Golden Pearl Trading Corp. is recalling certain ready-to-eat or RTE imported Siluriformes products that were produced without benefit of import inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves around 12,054 pounds of Siluriformes products that were not presented for import re-inspection into the United States. The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft...
Follow RTT
>